TB treatment regimen for children: is a 4-month regimen really better than the 6-month regimen?

Affiliations

¹ Department of Pulmonary Medicine & Critical Care, Bhubaneswar, India.
² Department of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, India.

Comment

A Datta et al. Int J Tuberc Lung Dis. 2022.

. 2022 Dec 1;26(12):1197.

doi: 10.5588/ijtld.22.0375.

¹ Department of Pulmonary Medicine & Critical Care, Bhubaneswar, India.
² Department of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, India.

No abstract available

Comment on

Clinical standards for drug-susceptible pulmonary TB.
Akkerman OW, Duarte R, Tiberi S, Schaaf HS, Lange C, Alffenaar JWC, Denholm J, Carvalho ACC, Bolhuis MS, Borisov S, Bruchfeld J, Cabibbe AM, Caminero JA, Carvalho I, Chakaya J, Centis R, Dalcomo MP, D Ambrosio L, Dedicoat M, Dheda K, Dooley KE, Furin J, García-García JM, van Hest NAH, de Jong BC, Kurhasani X, Märtson AG, Mpagama S, Torrico MM, Nunes E, Ong CWM, Palmero DJ, Ruslami R, Saktiawati AMI, Semuto C, Silva DR, Singla R, Solovic I, Srivastava S, de Steenwinkel JEM, Story A, Sturkenboom MGG, Tadolini M, Udwadia ZF, Verhage AR, Zellweger JP, Migliori GB. Akkerman OW, et al. Int J Tuberc Lung Dis. 2022 Jul 1;26(7):592-604. doi: 10.5588/ijtld.22.0228. Int J Tuberc Lung Dis. 2022. PMID: 35768923 Free PMC article.